0000315066-18-001774.txt : 20180405 0000315066-18-001774.hdr.sgml : 20180405 20180405122723 ACCESSION NUMBER: 0000315066-18-001774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180403 FILED AS OF DATE: 20180405 DATE AS OF CHANGE: 20180405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38443 FILM NUMBER: 18739899 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unum Therapeutics Inc. CENTRAL INDEX KEY: 0001622229 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465308248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-945-5576 MAIL ADDRESS: STREET 1: 200 CAMBRIDGE PARK DRIVE STREET 2: SUITE 3100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: Unum Therapeutics, Inc. DATE OF NAME CHANGE: 20141014 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-04-03 1 0001622229 Unum Therapeutics Inc. UMRX 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 0 1 See Remark 1 Common Stock 2018-04-03 4 C 0 349462 A 349462 I F-Prime Capital Partners Healthcare Fund IV LP Common Stock 2018-04-03 4 C 0 8601 A 358063 I F-Prime Capital Partners Healthcare Fund IV LP Common Stock 2018-04-03 4 P 0 94052 12 A 452115 I F-Prime Capital Partners Healthcare Fund IV LP Common Stock 2018-04-03 4 C 0 1890701 A 1890701 I Impresa Fund III Limited Partnership Common Stock 2018-04-03 4 C 0 46534 A 1937235 I Impresa Fund III Limited Partnership Common Stock 2018-04-03 4 C 0 22682 A 22682 I F-Prime Capital Partners Healthcare Advisors Fund IV LP Common Stock 2018-04-03 4 C 0 558 A 23240 I F-Prime Capital Partners Healthcare Advisors Fund IV LP Series A Preferred Stock 2018-04-03 4 C 0 548702 D Common Stock 349462 0 I F-Prime Capital Partners Healthcare Fund IV LP Series A Preferred Stock 2018-04-03 4 C 0 2968650 D Common Stock 1890701 0 I Impresa Fund III Limited Partnership Series A Preferred Stock 2018-04-03 4 C 0 35614 D Common Stock 22682 0 I F-Prime Capital Partners Healthcare Advisors Fund IV LP Series B Preferred Stock 2018-04-03 4 C 0 13505 D Common Stock 8601 0 I F-Prime Capital Partners Healthcare Fund IV LP Series B Preferred Stock 2018-04-03 4 C 0 73065 D Common Stock 46534 0 I Impresa Fund III Limited Partnership Series B Preferred Stock 2018-04-03 4 C 0 877 D Common Stock 558 0 I F-Prime Capital Partners Healthcare Advisors Fund IV LP On April 3, 2018, in connection with the completion of the issuer's initial public offering, each 1.5701314513884 shares of Series A and Series B Preferred Stock converted into 1 share of Common Stock. Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: The general partner of F-Prime Capital Partners Healthcare Fund IV LP is F-Prime Capital Partners Healthcare Advisors Fund IV LP (FPCPHA). FPCPHA is solely managed by Impresa Management LLC, the general partner of its general partner and its investment manager. Impresa Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. Marc R. Bryant, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson 2018-04-04